{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T09:33:42Z","timestamp":1793093622625,"version":"4.5.0"},"reference-count":85,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,15]],"date-time":"2023-06-15T00:00:00Z","timestamp":1686787200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"NIAID","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"NCATS","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.jaci.2023.05.026","type":"journal-article","created":{"date-parts":[[2023,6,12]],"date-time":"2023-06-12T20:48:23Z","timestamp":1686602903000},"page":"1179-1195","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":101,"title":["Rapid reduction in Staphylococcus aureus in atopic dermatitis subjects following dupilumab treatment"],"prefix":"10.1016","volume":"152","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0853-0252","authenticated-orcid":false,"given":"Eric L.","family":"Simpson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick M.","family":"Schlievert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Lussier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Boguniewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tissa","family":"Hata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zelma","family":"Fuxench","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"De Benedetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peck Y.","family":"Ong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agustin","family":"Calatroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda K.","family":"Rudman Spergel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marshall","family":"Plaut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally A.","family":"Quataert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel H.","family":"Kilgore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liam","family":"Peterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann L.","family":"Gill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria","family":"David","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Mosmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven R.","family":"Gill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0177-3844","authenticated-orcid":false,"given":"Donald Y.M.","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8452-667X","authenticated-orcid":false,"given":"Lisa A.","family":"Beck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2023.05.026_bib1","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jaci.2009.11.027","article-title":"Recent insights into atopic dermatitis and implications for management of infectious complications","volume":"125","author":"Boguniewicz","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2023.05.026_bib2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.anai.2020.08.002","article-title":"The infectious complications of atopic dermatitis","volume":"126","author":"Wang","year":"2021","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"260-9","key":"10.1016\/j.jaci.2023.05.026_bib3","first-page":"9e1","article-title":"Phenotype of atopic dermatitis subjects with a history of eczema herpeticum","volume":"124","author":"Beck","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2023.05.026_bib4","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.jaci.2011.02.010","article-title":"Human atopic dermatitis complicated by eczema herpeticum is associated with abnormalities in IFN-\u03b3 response","volume":"127","author":"Leung","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2023.05.026_bib5","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1111\/bjd.12382","article-title":"Atopic dermatitis complicated by eczema herpeticum is associated with HLA B7 and reduced interferon-\u03b3-producing CD8+ T cells","volume":"169","author":"Mathias","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2023.05.026_bib6","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.jaci.2014.07.018","article-title":"Identification of novel gene signatures in patients with atopic dermatitis complicated by eczema herpeticum","volume":"134","author":"Bin","year":"2014","journal-title":"J Allergy Clin Immunol"},{"issue":"186-93","key":"10.1016\/j.jaci.2023.05.026_bib7","first-page":"93e1","article-title":"Comparative proteomic profiling of patients with atopic dermatitis based on history of eczema herpeticum infection and Staphylococcus aureus colonization","volume":"127","author":"Broccardo","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2023.05.026_bib8","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1016\/j.jaci.2015.06.047","article-title":"Targeted deep sequencing identifies rare loss-of-function variants in IFNGR1 for risk of atopic dermatitis complicated by eczema herpeticum","volume":"136","author":"Gao","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2023.05.026_bib9","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1016\/j.jid.2018.03.1517","article-title":"Patients with atopic dermatitis colonized with Staphylococcus aureus have a distinct phenotype and endotype","volume":"138","author":"Simpson","year":"2018","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2023.05.026_bib10","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1128\/CMR.00104-12","article-title":"Staphylococcal and streptococcal superantigen exotoxins","volume":"26","author":"Spaulding","year":"2013","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.jaci.2023.05.026_bib11","doi-asserted-by":"crossref","first-page":"e00616","DOI":"10.1128\/mSphere.00616-19","article-title":"Staphylococcal virulence factors on the skin of atopic dermatitis patients","volume":"4","author":"Moran","year":"2019","journal-title":"mSphere"},{"key":"10.1016\/j.jaci.2023.05.026_bib12","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.jaci.2012.06.019","article-title":"Staphylococcus aureus \u03b1-toxin modulates skin host response to viral infection","volume":"130","author":"Bin","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2023.05.026_bib13","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1086\/586746","article-title":"Superantigen profile of Staphylococcus aureus isolates from patients with steroid-resistant atopic dermatitis","volume":"46","author":"Schlievert","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jaci.2023.05.026_bib14","doi-asserted-by":"crossref","DOI":"10.1128\/mSphere.00608-21","article-title":"Staphylococcal TSST-1 association with eczema herpeticum in humans","volume":"6","author":"Schlievert","year":"2021","journal-title":"mSphere"},{"key":"10.1016\/j.jaci.2023.05.026_bib15","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1016\/S0002-9378(03)00873-1","article-title":"Penetration of toxic shock syndrome toxin-1 across porcine vaginal mucosa ex\u00a0vivo: permeability characteristics, toxin distribution, and tissue damage","volume":"189","author":"Davis","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jaci.2023.05.026_bib16","doi-asserted-by":"crossref","first-page":"e00295","DOI":"10.1128\/mSphere.00295-16","article-title":"Temporal and racial differences associated with atopic dermatitis Staphylococcus aureus and encoded virulence factors","volume":"1","author":"Merriman","year":"2016","journal-title":"mSphere"},{"key":"10.1016\/j.jaci.2023.05.026_bib17","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.3390\/genes10121036","article-title":"High prevalence of Staphylococcus aureus enterotoxin gene cluster superantigens in cystic fibrosis clinical isolates","volume":"10","author":"Fischer","year":"2019","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.jaci.2023.05.026_bib18","doi-asserted-by":"crossref","first-page":"937","DOI":"10.7326\/0003-4819-96-6-937","article-title":"Toxin and enzyme characterization of Staphylococcus aureus isolates from patients with and without toxic shock syndrome","volume":"96","author":"Schlievert","year":"1982","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jaci.2023.05.026_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.xjidi.2021.100018","article-title":"Characterization of human keratinocyte cell lines for barrier studies","volume":"1","author":"Moran","year":"2021","journal-title":"JID Innov"},{"key":"10.1016\/j.jaci.2023.05.026_bib20","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.jid.2019.05.024","article-title":"IL-4Ralpha blockade by dupilumab decreases Staphylococcus aureus colonization and increases microbial diversity in atopic dermatitis","volume":"140","author":"Callewaert","year":"2020","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2023.05.026_bib21","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/j.jaip.2022.02.026","article-title":"Dupilumab demonstrates rapid onset of response across three type 2 inflammatory diseases","volume":"10","author":"Canonica","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2023.05.026_bib22","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/pde.14909","article-title":"Infections in children and adolescents treated with dupilumab in pediatric clinical trials for atopic dermatitis: a pooled analysis of trial data","volume":"39","author":"Paller","year":"2022","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.jaci.2023.05.026_bib23","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1046\/j.1365-2133.2000.03300.x","article-title":"The Nottingham Eczema Severity Score: preliminary refinement of the Rajka and Langeland grading","volume":"142","author":"Emerson","year":"2000","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2023.05.026_bib24","unstructured":"CDC\/NCHS. Healthy weight, overweight, and obesity among U.S. adults. Atlanta, Georgia: Center for Disease Control."},{"key":"10.1016\/j.jaci.2023.05.026_bib25","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/j.1525-1470.2003.20601.x","article-title":"Validation of a self-administered questionnaire in Chinese in the assessment of eczema severity","volume":"20","author":"Hon","year":"2003","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.jaci.2023.05.026_bib26","doi-asserted-by":"crossref","first-page":"10S","DOI":"10.1177\/1203475418803628","article-title":"Approach to the assessment and management of adult patients with atopic dermatitis: a consensus document. Section II: tools for assessing the severity of atopic dermatitis","volume":"22","author":"Gooderham","year":"2018","journal-title":"J Cutan Med Surg"},{"key":"10.1016\/j.jaci.2023.05.026_bib27","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s13075-020-02190-3","article-title":"Serum calprotectin: a promising biomarker in rheumatoid arthritis and axial spondyloarthritis","volume":"22","author":"Jarlborg","year":"2020","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jaci.2023.05.026_bib28","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1042\/CS20171592","article-title":"More than a simple biomarker: the role of NGAL in cardiovascular and renal diseases","volume":"132","author":"Buonafine","year":"2018","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.jaci.2023.05.026_bib29","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1365-2230.2011.04265.x","article-title":"Serum lipocalin-2 levels are increased in patients with psoriasis","volume":"37","author":"Kamata","year":"2012","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaci.2023.05.026_bib30","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/JLB.3COVCRA0720-359R","article-title":"Neutrophil calprotectin identifies severe pulmonary disease in COVID-19","volume":"109","author":"Shi","year":"2021","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.jaci.2023.05.026_bib31","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.atherosclerosis.2011.11.023","article-title":"Increased plasma levels of NGAL, a marker of neutrophil activation, in patients with abdominal aortic aneurysm","volume":"220","author":"Ramos-Mozo","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jaci.2023.05.026_bib84","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol"},{"key":"10.1016\/j.jaci.2023.05.026_bib32","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/nar\/28.1.27","article-title":"KEGG: Kyoto Encyclopedia of Genes and Genomes","volume":"28","author":"Kanehisa","year":"2000","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jaci.2023.05.026_bib33","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1002\/pro.3715","article-title":"Toward understanding the origin and evolution of cellular organisms","volume":"28","author":"Kanehisa","year":"2019","journal-title":"Protein Sci"},{"key":"10.1016\/j.jaci.2023.05.026_bib34","doi-asserted-by":"crossref","first-page":"D545","DOI":"10.1093\/nar\/gkaa970","article-title":"KEGG: integrating viruses and cellular organisms","volume":"49","author":"Kanehisa","year":"2021","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jaci.2023.05.026_bib35","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1038\/ni1497","article-title":"Development, cytokine profile and function of human interleukin 17-producing helper T cells","volume":"8","author":"Wilson","year":"2007","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaci.2023.05.026_bib36","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.3390\/ijms21041275","article-title":"Interleukin-17A and keratinocytes in psoriasis","volume":"21","author":"Furue","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jaci.2023.05.026_bib37","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1172\/JCI40891","article-title":"IL-17 is essential for host defense against cutaneous Staphylococcus aureus infection in mice","volume":"120","author":"Cho","year":"2010","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2023.05.026_bib38","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1038\/ni.3211","article-title":"T(H)17 cells promote microbial killing and innate immune sensing of DNA via interleukin 26","volume":"16","author":"Meller","year":"2015","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaci.2023.05.026_bib39","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1002\/cyto.a.22445","article-title":"SWIFT-scalable clustering for automated identification of rare cell populations in large, high-dimensional flow cytometry datasets, part 2: biological evaluation","volume":"85","author":"Mosmann","year":"2014","journal-title":"Cytometry A"},{"key":"10.1016\/j.jaci.2023.05.026_bib40","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1002\/cyto.a.22446","article-title":"SWIFT-scalable clustering for automated identification of rare cell populations in large, high-dimensional flow cytometry datasets, part 1: algorithm design","volume":"85","author":"Naim","year":"2014","journal-title":"Cytometry A"},{"key":"10.1016\/j.jaci.2023.05.026_bib41","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J Royal Stat Soc Ser B (Methodol)"},{"key":"10.1016\/j.jaci.2023.05.026_bib42","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1038\/s41591-021-01256-2","article-title":"Development of a human skin commensal microbe for bacteriotherapy of atopic dermatitis and use in a phase 1 randomized clinical trial","volume":"27","author":"Nakatsuji","year":"2021","journal-title":"Nat Med"},{"key":"10.1016\/j.jaci.2023.05.026_bib43","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s40257-019-00445-7","article-title":"Infections in dupilumab clinical trials in atopic dermatitis: a comprehensive pooled analysis","volume":"20","author":"Eichenfield","year":"2019","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.jaci.2023.05.026_bib44","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/bjd.14566","article-title":"Prevalence and odds of Staphylococcus aureus carriage in atopic dermatitis: a systematic review and meta-analysis","volume":"175","author":"Tott\u00e9","year":"2016","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2023.05.026_bib45","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1159\/000323905","article-title":"Staphylococcal \u03b1-toxin induces a higher T cell proliferation and interleukin-31 in atopic dermatitis","volume":"156","author":"Niebuhr","year":"2011","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaci.2023.05.026_bib46","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1016\/j.jaci.2010.07.041","article-title":"Staphylococcal exotoxins are strong inducers of IL-22: a potential role in atopic dermatitis","volume":"126","author":"Niebuhr","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2023.05.026_bib47","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0158969","article-title":"Local epidermal growth factor receptor signaling mediates the systemic pathogenic effects of Staphylococcus aureus toxic shock syndrome","volume":"11","author":"Breshears","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jaci.2023.05.026_bib48","doi-asserted-by":"crossref","first-page":"202","DOI":"10.3390\/toxins9070202","article-title":"Epidermal growth factor receptor signaling enhances the proinflammatory effects of Staphylococcus aureus gamma-toxin on the mucosa","volume":"9","author":"Gillman","year":"2017","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.jaci.2023.05.026_bib49","doi-asserted-by":"crossref","first-page":"593","DOI":"10.4168\/aair.2019.11.5.593","article-title":"Interactions between atopic dermatitis and Staphylococcus aureus infection: clinical implications","volume":"11","author":"Kim","year":"2019","journal-title":"Allergy Asthma Immunol Res"},{"key":"10.1016\/j.jaci.2023.05.026_bib50","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1111\/j.0022-202X.2005.23916.x","article-title":"Staphylococcus aureus clonal dynamics and virulence factors in children with atopic dermatitis","volume":"125","author":"Lomholt","year":"2005","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2023.05.026_bib51","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1001\/archderm.1996.03890250037007","article-title":"Staphylococcal enterotoxin B applied on intact normal and intact atopic skin induces dermatitis","volume":"132","author":"Strange","year":"1996","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaci.2023.05.026_bib52","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0091-6749(99)70535-X","article-title":"Prevalence and role of serum IgE antibodies to the Staphylococcus aureus-derived superantigens SEA and SEB in children with atopic dermatitis","volume":"103","author":"Bunikowski","year":"1999","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2023.05.026_bib53","doi-asserted-by":"crossref","first-page":"273","DOI":"10.2165\/00128071-200607050-00001","article-title":"Role of bacterial superantigens in atopic dermatitis : implications for future therapeutic strategies","volume":"7","author":"Cardona","year":"2006","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.jaci.2023.05.026_bib54","doi-asserted-by":"crossref","first-page":"762","DOI":"10.4168\/aair.2021.13.5.762","article-title":"Dupilumab therapy improves stratum corneum hydration and skin dysbiosis in patients with atopic dermatitis","volume":"13","author":"Lee","year":"2021","journal-title":"Allergy Asthma Immunol Res"},{"key":"10.1016\/j.jaci.2023.05.026_bib55","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.3390\/microorganisms9071487","article-title":"Changes in Skin and nasal microbiome and Staphylococcal species following treatment of atopic dermatitis with dupilumab","volume":"9","author":"Olesen","year":"2021","journal-title":"Microorganisms"},{"key":"10.1016\/j.jaci.2023.05.026_bib56","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aah4680","article-title":"Antimicrobials from human skin commensal bacteria protect against Staphylococcus aureus and are deficient in atopic dermatitis","volume":"9","author":"Nakatsuji","year":"2017","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jaci.2023.05.026_bib57","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.00930-22","article-title":"The ubiquitous human skin commensal Staphylococcus hominis protects against opportunistic pathogens","volume":"13","author":"Severn","year":"2022","journal-title":"mBio"},{"key":"10.1016\/j.jaci.2023.05.026_bib58","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aal4651","article-title":"Staphylococcus aureus and Staphylococcus epidermidis strain diversity underlying pediatric atopic dermatitis","volume":"9","author":"Byrd","year":"2017","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jaci.2023.05.026_bib59","doi-asserted-by":"crossref","first-page":"3388","DOI":"10.1111\/all.15432","article-title":"Dupilumab significantly improves skin barrier function in patients with moderate-to-severe atopic dermatitis","volume":"77","author":"Berdyshev","year":"2022","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2023.05.026_bib60","doi-asserted-by":"crossref","first-page":"6720","DOI":"10.3390\/ijms14046720","article-title":"Cytokines and the skin barrier","volume":"14","author":"Hanel","year":"2013","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jaci.2023.05.026_bib61","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/nyas.13418","article-title":"Biphasic influence of Staphylococcus aureus on human epidermal tight junctions","volume":"1405","author":"Basler","year":"2017","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jaci.2023.05.026_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.xjidi.2022.100131","article-title":"Type 2 inflammation contributes to skin barrier dysfunction in atopic dermatitis","volume":"2","author":"Beck","year":"2022","journal-title":"JID Innov"},{"key":"10.1016\/j.jaci.2023.05.026_bib63","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.3390\/cells11081337","article-title":"Conditions that simulate the environment of atopic dermatitis enhance susceptibility of human keratinocytes to vaccinia virus","volume":"11","author":"Brewer","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.jaci.2023.05.026_bib85","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1056\/NEJMoa021481","article-title":"Endogenous antimicrobial peptides and skin infections in atopic dermatitis","volume":"347","author":"Ong","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2023.05.026_bib64","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1038\/jid.2009.432","article-title":"Enhanced expression and secretion of antimicrobial peptides in atopic dermatitis and after superficial skin injury","volume":"130","author":"Harder","year":"2010","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2023.05.026_bib65","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.imbio.2011.10.010","article-title":"Increased serum human \u03b2-defensin-2 levels in atopic dermatitis: relationship to IL-22 and oncostatin M","volume":"217","author":"Kanda","year":"2012","journal-title":"Immunobiology"},{"key":"10.1016\/j.jaci.2023.05.026_bib66","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1093\/infdis\/jit527","article-title":"Influenza A\u00a0virus exacerbates Staphylococcus aureus pneumonia in mice by attenuating antimicrobial peptide production","volume":"209","author":"Robinson","year":"2014","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jaci.2023.05.026_bib67","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1189\/jlb.0103024","article-title":"Many chemokines including CCL20\/MIP-3alpha display antimicrobial activity","volume":"74","author":"Yang","year":"2003","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.jaci.2023.05.026_bib68","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0060463","article-title":"Host gene expression profiling and in\u00a0vivo cytokine studies to characterize the role of linezolid and vancomycin in methicillin-resistant Staphylococcus aureus (MRSA) murine sepsis model","volume":"8","author":"Sharma-Kuinkel","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jaci.2023.05.026_bib69","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.chom.2011.07.004","article-title":"Nutrient metal sequestration by calprotectin inhibits bacterial superoxide defense, enhancing neutrophil killing of Staphylococcus aureus","volume":"10","author":"Kehl-Fie","year":"2011","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.jaci.2023.05.026_bib70","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2021.757215","article-title":"The kinocidin interleukin-26 shows immediate antimicrobial effects even to multi-resistant isolates","volume":"12","author":"Hansen","year":"2021","journal-title":"Front Microbiol"},{"key":"10.1016\/j.jaci.2023.05.026_bib71","doi-asserted-by":"crossref","unstructured":"Leyva-Castillo JM, McGurk A, Strakosha M, Vega-Mendoza D, Smith S, Stafstrom K, et\u00a0al. IL-4 receptor alpha blockade dampens allergic inflammation and upregulates IL-17A expression to promote S aureus clearance in antigen sensitized mouse skin. J Allergy Clin Immunol 2023 Jun 12:S0091-6749(23)00755-8. https:\/\/doi.org\/10.1016\/j.jaci.2023.05.025. Epub ahead of print.","DOI":"10.1016\/j.jaci.2023.05.025"},{"key":"10.1016\/j.jaci.2023.05.026_bib72","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1056\/NEJMoa1314768","article-title":"Dupilumab treatment in adults with moderate-to-severe atopic dermatitis","volume":"371","author":"Beck","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2023.05.026_bib73","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jaci.2020.06.012","article-title":"Atopic dermatitis displays stable and dynamic skin transcriptome signatures","volume":"147","author":"Mobus","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2023.05.026_bib74","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jaci.2018.08.022","article-title":"Dupilumab progressively improves systemic and cutaneous abnormalities in patients with atopic dermatitis","volume":"143","author":"Guttman-Yassky","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2023.05.026_bib75","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.jaci.2019.01.042","article-title":"IL-4 receptor engagement in human neutrophils impairs their migration and extracellular trap formation","volume":"144","author":"Impellizzieri","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2023.05.026_bib76","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.immuni.2016.06.025","article-title":"Type 2 interleukin-4 receptor signaling in neutrophils antagonizes their expansion and migration during infection and inflammation","volume":"45","author":"Woytschak","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2023.05.026_bib77","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.coi.2018.06.009","article-title":"Regulation of neutrophils in type 2 immune responses","volume":"54","author":"Heeb","year":"2018","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.jaci.2023.05.026_bib78","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.3389\/fimmu.2019.02507","article-title":"The regulatory effects of interleukin-4 receptor signaling on neutrophils in type 2 immune responses","volume":"10","author":"Egholm","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2023.05.026_bib79","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/bjd.20064","article-title":"Dupilumab-induced phenotype switch from atopic dermatitis to psoriasis is characterized by\u00a0de novo interleukin-17A expression: a case report","volume":"185","author":"Mirza","year":"2021","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2023.05.026_bib80","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1111\/pde.14820","article-title":"Psoriasiform dermatitis during dupilumab treatment for moderate-to-severe atopic dermatitis in children","volume":"38","author":"Parker","year":"2021","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.jaci.2023.05.026_bib81","doi-asserted-by":"crossref","first-page":"2660","DOI":"10.1016\/j.jid.2022.03.013","article-title":"T helper 2 IL-4\/IL-13 dual blockade with dupilumab is linked to some emergent T helper 17 type diseases, including seronegative arthritis and enthesitis\/enthesopathy,\u00a0but not to humoral autoimmune diseases","volume":"142","author":"Bridgewood","year":"2022","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2023.05.026_bib82","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.jaip.2021.08.042","article-title":"Relieving job: dupilumab in autosomal dominant STAT3 hyper-IgE syndrome","volume":"10","author":"Staudacher","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2023.05.026_bib83","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1365-2133.2010.09743.x","article-title":"Interventions to reduce Staphylococcus aureus in the management of atopic eczema: an updated Cochrane review","volume":"163","author":"Bath-Hextall","year":"2010","journal-title":"Br J Dermatol"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674923007546?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674923007546?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T09:45:31Z","timestamp":1758793531000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674923007546"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":85,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S0091674923007546"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2023.05.026","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rapid reduction in Staphylococcus aureus in atopic dermatitis subjects following dupilumab treatment","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2023.05.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology.","name":"copyright","label":"Copyright"}]}}